Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation
Int J Cardiol Heart Vasc
.
2024 Mar 20:52:101387.
doi: 10.1016/j.ijcha.2024.101387.
eCollection 2024 Jun.
Authors
Makoto Nakano
1
,
Satoshi Yasuda
1
,
Yuhi Hasebe
1
,
Kotaro Nochioka
1
,
Koji Fukuda
1
,
Jun Takahashi
1
,
Hiroaki Shimokawa
1
Affiliation
1
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
PMID:
38854744
PMCID:
PMC11156700
DOI:
10.1016/j.ijcha.2024.101387
No abstract available
Keywords:
Direct oral anticoagulants; Protease-activated-receptor.